Janaki Kuruppu is an Infectious Disease physician affiliated with National Institutes of Health Clinical Center. OpenAlex indexes 18 publications with 3,183 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
10801 Lockwood Dr Ste 160
Silver Spring, MD 209011586
Telephone
301-298-1040Provider last certified this registry record 14 Apr 2026.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20253 payments
- Gilead Sciences, Inc.Program year20251 payment
- Inspire Medical Systems, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2019)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
42.5%ACE inhibitor16.1%Lisinopril100%Part D<11 patientsCalcium channel blocker11.8%Amlodipine Besylate100%Part D<11 patients+ 3 more classes in this area
Anti-infectives
34.6%Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor11.5%Triumeq39%Descovy32%Truvada29%Part D<11 patientsHuman Immunodeficiency Virus Integrase Strand Transfer Inhibitor7.6%Tivicay52%Isentress48%Part D<11 patients+ 3 more classes in this area
Nervous system
13%Partial Opioid Agonist5.4%Suboxone100%Part D<11 patientsSSRI4.5%Trazodone Hcl100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Single Dose Study of Pembrolizumab in People With HIV Infection Who are Immunologic Nonresponders
Open Forum Infectious Diseases
2026 - Transcriptionally Active Defective HIV-1 Proviruses and Their Association With Immunological Nonresponse to Antiretroviral Therapy
The Journal of Infectious Diseases
2024 - Longitudinal Analysis of the Lung Proteome Reveals Persistent Repair Months after Mild to Moderate COVID-19
SSRN Electronic Journal
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Yousef Khader
Jordan University of Science and Technology
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Derrick W. Crook
Nuffield Orthopaedic Centre
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”